Product Program year 2025 Source: CMS Open Payments

Fluzone Trivalent

Biological Vaccines

NDC 83703-061-50

Open in the dashboard

General payments

$4,194

191 payments

Research payments

$0

0 payments

Through program year 2025, $4,194 in general payments and $0 in research payments were reported against Fluzone Trivalent (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $4,028 182
2024 General $165 9

Breakdown

Who paid General payments · program years 2024–2025
  1. Sanofi Pasteur Inc. $4,194 191 payments
Top recipients General payments · program year 2025
  1. Yasmine Monib Pediatrics · Katy, TX $63 2% · 2 payments
  2. Giuseppe Lancellotti Pediatrics · Ephrata, PA $62 2% · 2 payments
  3. John Beckerman Pediatrics · Barrington, IL $54 1% · 1 payment
  4. Claudine Baggio Pediatrics · Barrington, IL $54 1% · 1 payment
  5. Barry Sommerfeld Pediatrics · Schaumburg, IL $46 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatrics $1,916 48% · 79 practitioners
  2. Family Medicine $518 13% · 25 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $359 9% · 17 practitioners
  4. Adolescent Medicine Pediatrics $218 5% · 10 practitioners
  5. Internal Medicine $199 5% · 9 practitioners

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $607 15% · 27 recipients
  2. Florida $393 10% · 16 recipients
  3. Pennsylvania $373 9% · 15 recipients
  4. Illinois $351 9% · 13 recipients
  5. Georgia $239 6% · 12 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

191 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record